GORE EXCLUDER AAA ENDOPROSTHESIS
Report
- Report Number
- 2953161-2011-00138
- Event Type
- Injury
- Date Received
- June 13, 2011
- Date of Event
- May 18, 2011
- Report Date
- June 13, 2011
- Manufacturer
- W. L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- PHYSICIAN
Narratives
A REVIEW OF THE MFG PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. ANEURYSM GROWTH IN THE ABSENCE OF ENDOLEAK HAS BEEN DEFINED AS ENDOTENSION. ONE HYPOTHESIS FOR THE SOURCE OF ENDOTENSION IS THE TRANSMURAL MOVEMENT OF SERIOUS FLUID ACROSS THE MATERIAL USED TO FABRICATE DEVICES USED TO TREAT THE AORTIC ABDOMINAL ANEURYSM. IN RESPONSE TO THIS ISSUE, GORE ELECTED TO PROVIDE A DESIGN ENHANCEMENT TO THE ORIGINAL GORE EXCLUDER BIFURCATED ENDOPROSTHESIS.
ON (B)(6) 2003, THIS PT WAS IMPLANTED WITH GORE EXCLUDER BIFURCATED ENDOPROSTHESIS FOR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM. APPROX TWO WEEKS BEFORE REINTERVENTION, CT SCAN REVEALED ANEURYSM GROWTH WITH NO SIGN OF ENDOLEAK. ON (B)(6) 2011, THIS PT HAD A REINTERVENTION TO TREAT ANEURYSM GROWTH WITH NO SIGN OF ENDOLEAK. ADDITIONAL GORE EXCLUDER AAA ENDOPROSTHESES WERE IMPLANTED TO RELINE THE GRAFT. THE PT TOLERATED THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W. L. GORE & ASSOCIATES | WLG425 | 032090601 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| R | PCL161407/(B)(4)| PCA280300/(B)(4)| PCC201400/(B)(4)| PCC201200/(B)(4)| PCA280300/(B)(4)| PCL161407/(B)(4) |